0IMT.LSE Photocure ASA

Healthcare Oil, Gas & Consumable Fuels London Exchange
63.44 NOK
Close of Nov 3, 2026
45.00 79.60
Market cap
NOK 1.37B
P/E
-
P/B
-
ROE
12.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0IMT.LSE undervalued?

Graham number

The Graham number of Photocure ASA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Photocure ASA fundamental analysis

No fundamental analysis for Photocure ASA yet.

Photocure ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and Development Portfolio. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination product candidate for the non-surgical treatment of high-grade cervical dysplasia. …

Full company profile